BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PRX-115 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PRX-115\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07280156-10979@assetmemo.bio
DTSTAMP:20261121T005823Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:PRX-115: Phase 2 readout est. (NCT07280156)
DESCRIPTION:PRX-115\, phase 2.\nStudy: A Study to Investigate the Clinical 
 Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing
  Regimens\, With and Without Methotrexate\, Versus Placebo in Adults Gout 
 Patients (RELEASE)\nEstimated primary completion: December 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/prx-115#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07280156
URL:https://assetmemo.bio/drug/prx-115#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
